Mainz BioMed NV

Contributing Author

Recent Articles by Mainz BioMed NV

Oct-15	Mainz Biomed to Attend 2025 Maxim Growth Summit MYNZ GlobeNewswire
Oct-08	Mainz Biomed Reports Topline Results from Feasibility Study of Biomarker Panel in Pancreatic Cancer Project MYNZ GlobeNewswire
Sep-30	Mainz Biomed to Present the Future of Colorectal Cancer Screening at WEO CRC Screening Committee Meeting MYNZ GlobeNewswire
Sep-23	Mainz Biomed Announces Commercial Launch of ColoAlert in Switzerland MYNZ GlobeNewswire
Sep-02	Mainz Biomed Announces Registration of ColoAlert in the United Kingdom MYNZ GlobeNewswire
Aug-13	Mainz Biomed Receives Swiss Regulatory Approval to Market ColoAlert MYNZ GlobeNewswire
Aug-04	Mainz Biomed Announces Pricing of $3.0 Million Follow-On Offering of Ordinary Shares and Warrants MYNZ GlobeNewswire
Jul-23	Mainz Biomed and CARE Conclude Cooperation Agreement for Joint Care Concept for Health Insurance Companies MYNZ GlobeNewswire
Jul-15	Mainz Biomed Half Year 2025 Update: Accelerating FDA Pathway for NextGen Colorectal Cancer Screening and Expansion with Pancreatic Cancer Screening Acquisition MYNZ GlobeNewswire
Jun-25	Mainz Biomed Secures Public Funding to Advance Innovative Pancreatic Cancer Screening Test MYNZ GlobeNewswire
Jun-10	Mainz Biomed Initiates Feasibility Study of Biomarker Panel in Pancreatic Cancer Project MYNZ GlobeNewswire
May-19	Mainz Biomed Announces Pricing of $4.0 Million Follow-On Offering of Ordinary Shares and Warrants MYNZ GlobeNewswire
May-16	Mainz Biomed Announces Interim Read Out For Its eAArly DETECT 2 Clinical Study MYNZ GlobeNewswire

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2025 Finviz.com. All Rights Reserved.